XML 102 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current assets:      
Cash and cash equivalents $ 2,000 $ 1,000 $ 2,000
Accounts receivable, net 128,000 128,000  
Other receivables   128,000
Current portion of notes receivable 203,000 203,000 16,000
Prepaid expenses and other current assets 2,000 104,000
Total current assets 335,000 332,000 122,000
Other investments   782,000
Notes receivable 203,000 190,000
Property, plant and equipment, net 285,000 287,000 276,000
Goodwill 25,093,000 25,093,000 25,093,000
Other intangible assets, net 18,643,000 18,921,000 20,034,000
Total assets 44,356,000 44,633,000 46,497,000
Current liabilities:      
Accounts payable 1,023,000 832,000 539,000
Accrued expenses 47,000 230,000 63,000
Note payable, related party 12,787,000 12,074,000 9,991,000
Total current liabilities 13,857,000 13,136,000 10,593,000
Deferred tax liability, net 3,235,000 3,235,000 3,235,000
Total Liabilities   16,371,000 13,828,000
Commitments and contingencies (Note 12)
Stockholders’ equity      
Preferred stock, $0.001 par value; 100,000,000 shares authorized, 60,496,041 shares issued and outstanding (0 shares issued and outstanding on December 31, 2022); Liquidation value $0.001 per share, $60,000, ($0 aggregate on December 31, 2022). 60,000 60,000
Common stock, $0.001 par value; 4,000,000,000 shares authorized, 10,000,000 shares issued and outstanding (70,496,041 on December 31, 2022) 10,000 10,000 70,000
Additional paid-in capital 38,113,000 38,113,000 38,113,000
Accumulated deficit (13,923,000) (12,961,000) (8,625,000)
Total stockholders’ equity of the company 24,260,000 25,222,000 29,558,000
Non-controlling interest in subsidiary 3,004,000 3,040,000 3,111,000
Total stockholder’s equity 27,264,000 28,262,000 32,669,000
Total liabilities and stockholders’ equity $ 44,356,000 $ 44,633,000 $ 46,497,000